Strategies for modulating innate immune activation and protein production of in vitro transcribed mRNAs

Journal of Materials Chemistry B

Volumn 4, Issue 9, 2016, Pages 1619-1632

  Loomis, Kristin H ^a   Kirschman, Jonathan L ^a   Bhosle, Sushma ^a   Bellamkonda, Ravi V ^a   Santangelo, Philip J ^a  

^a Emory University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; GENE THERAPY; GENE TRANSFER; GENES; PLANNING; VACCINES;

CODON OPTIMIZATION; DELIVERY VEHICLE; MODIFIED NUCLEOTIDES; PROTEIN EXPRESSIONS; PROTEIN PRODUCTION; SUBUNIT VACCINE; THERAPEUTIC PROTEIN; UNTRANSLATED REGIONS;

PROTEINS;

EID: 84959450353     PISSN: 20507518     EISSN: 2050750X     Source Type: Journal    
DOI: 10.1039/c5tb01753j     Document Type: Article

References (122)

1. G. Walsh R. Jefferis Post-translational modifications in the context of therapeutic proteins Nat. Biotechnol. 2006 24 1241 1252
2. Y. H. Wang H. H. Su Y. Yang Y. X. Hu L. Zhang P. Blancafort L. Huang Systemic Delivery of Modified mRNA Encoding Herpes Simplex Virus 1 Thymidine Kinase for Targeted Cancer Gene Therapy Mol. Ther. 2013 21 358 367
3. V. F. I. Van Tendeloo P. Ponsaerts F. Lardon G. Nijs M. Lenjou C. Van Broeckhoven D. R. Van Bockstaele Z. N. Berneman Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells Blood 2001 98 49 56
4. S. Zou K. Scarfo M. H. Nantz J. G. Hecker Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells Int. J. Pharm. 2010 389 232 243
5. U. Sahin K. Kariko O. Tureci mRNA-based therapeutics-developing a new class of drugs Nat. Rev. Drug Discovery 2014 13 759 780
6. K. Kariko H. Muramatsu F. A. Welsh J. Ludwig H. Kato S. Akira D. Weissman Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability Mol. Ther. 2008 16 1833 1840
7. M. S. D. Kormann G. Hasenpusch M. K. Aneja G. Nica A. W. Flemmer S. Herber-Jonat M. Huppmann L. E. Mays M. Illenyi A. Schams et al., Expression of therapeutic proteins after delivery of chemically modified mRNA in mice Nat. Biotechnol. 2011 29 154
8. S. G. Andreas Thess B. L. Mui M. J. Hope P. Baumhof M. Fotin-Mleczek T. Schlake Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals Mol. Ther. 2015 23 1456 1464 10.1038/mt.2015
9. B. Petsch M. Schnee A. B. Vogel E. Lange B. Hoffmann D. Voss T. Schlake A. Thess K. J. Kallen L. Stitz et al., Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection Nat. Biotechnol. 2012 30 1210 1216
10. K. Kariko H. Muramatsu J. Ludwig D. Weissman Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA Nucleic Acids Res. 2011 39 e142
11. L. Warren P. D. Manos T. Ahfeldt Y. H. Loh H. Li F. Lau W. Ebina P. K. Mandal Z. D. Smith A. Meissner et al., Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA Cell Stem Cell 2010 7 618 630
12. K. Kariko H. Muramatsu J. M. Keller D. Weissman Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin Mol. Ther. 2012 20 948 953
13. K. O. Lui L. Zangi E. A. Silva L. Bu M. Sahara R. A. Li D. J. Mooney K. R. Chien Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA Cell Res. 2013 23 1172 1186
14. L. Zangi K. O. Lui A. von Gise Q. Ma W. Ebina L. M. Ptaszek D. Spater H. S. Xu M. Tabebordbar R. Gorbatov et al., Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction Nat. Biotechnol. 2013 31 898 907
15. H. Kubler B. Scheel U. Gnad-Vogt K. Miller W. Schultze-Seemann F. Vom Dorp G. Parmiani C. Hampel S. Wedel L. Trojan et al., Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa studyl J. Immunother. Cancer 2015 3 26
16. S. Rausch C. Schwentner A. Stenzl J. Bedke mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer Hum. Vaccines Immunother. 2014 10 3146 3152
17. B. Weide J. P. Carralot A. Reese B. Scheel T. K. Eigentler I. Hoerr H. G. Rammensee C. Garbe S. Pascolo Results of the first phase I/II clinical vaccination trial with direct injection of mRNA J. Immunother. 2008 31 180 188
18. B. Weide S. Pascolo B. Scheel E. Derhovanessian A. Pflugfelder T. K. Eigentler G. Pawelec I. Hoerr H. G. Rammensee C. Garbe Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients J. Immunother. 2009 32 498 507
19. M. Fotin-Mleczek K. Zanzinger R. Heidenreich C. Lorenz A. Kowalczyk K. J. Kallen S. M. Huber mRNA-based vaccines synergize with radiation therapy to eradicate established tumors Radiat. Oncol. 2014 9 180
20. E. Roesler R. Weiss E. E. Weinberger A. Fruehwirth A. Stoecklinger S. Mostbock F. Ferreira J. Thalhamer S. Scheiblhofer Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens J. Allergy Clin. Immunol. 2009 124 1070 1077
21. E. Gilboa J. Vieweg Cancer immunotherapy with mRNA-transfected dendritic cells Immunol. Rev. 2004 199 251 263
22. E. J. Sayour L. Sanchez-Perez C. Flores D. A. Mitchell Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics J. Immunother. Cancer 2015 3 13
23. D. J. Hogan D. P. Riordan A. P. Gerber D. Herschlag P. O. Brown Diverse RNA-Binding Proteins Interact with Functionally Related Sets of RNAs, Suggesting an Extensive Regulatory System PLoS Biol. 2008 6 2297 2313
24. G. Singh A. Kucukural C. Cenik J. D. Leszyk S. A. Shaffer Z. P. Weng M. J. Moore The Cellular EJC Interactome Reveals Higher-Order mRNP Structure and an EJC-SR Protein Nexus Cell 2012 151 750 764
25. A. Bregman M. Avraham-Kelbert O. Barkai L. Duek A. Guterman M. Choder Promoter Elements Regulate Cytoplasmic mRNA Decay Cell 2011 147 1473 1483
26. L. E. Maquat W. Y. Tarn O. Isken The Pioneer Round of Translation: Features and Functions Cell 2010 142 368 374
27. J. Sauliere N. Haque S. Harms I. Barbosa M. Blanchette H. Le Hir The exon junction complex differentially marks spliced junctions Nat. Struct. Mol. Biol. 2010 17 1269 1271
28. R. Mendez J. D. Richter Translational control by CPEB: a means to the end Nat. Rev. Mol. Cell Biol. 2001 2 521 529
29. E. Matoulkova E. Michalova B. Vojtesek R. Hrstka The role of the 3′ untranslated region in post-transcriptional regulation of protein expression in mammalian cells RNA Biol. 2012 9 563 576
30. S. Djuranovic A. Nahvi R. Green miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay Science 2012 336 237 240
31. N. L. Garneau J. Wilusz C. J. Wilusz The highways and byways of mRNA decay Nat. Rev. Mol. Cell Biol. 2007 8 113 126
32. C. Lorenz M. Fotin-Mleczek G. Roth C. Becker T. C. Dam W. P. R. Verdurmen R. Brock J. Probst T. Schlake Protein expression from exogenous mRNA Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway RNA Biol. 2011 8 627 636
33. S. Bire D. Gosset G. Jegot P. Midoux C. Pichon F. Rouleux-Bonnin Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition BMC Biotechnol. 2013 13 10.1186/1472-6750-13-75
34. P. Anderson N. Kedersha Stress granules: The Tao of RNA triage Trends Biochem. Sci. 2008 33 141 150
35. F. Azmi A. A. A. Fuaad M. Skwarczynski I. Toth Recent progress in adjuvant discovery for peptide-based subunit vaccines Hum. Vaccines Immunother. 2014 10 778 796
36. R. E. Randall S. Goodbourn Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures J. Gen. Virol. 2008 89 1 47
37. B. R. Anderson H. Muramatsu S. R. Nallagatla P. C. Bevilacqua L. H. Sansing D. Weissman K. Kariko Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation Nucleic Acids Res. 2010 38 5884 5892
38. B. R. Anderson H. Muramatsu B. K. Jha R. H. Silverman D. Weissman K. Kariko Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L Nucleic Acids Res. 2011 39 9329 9338
39. C. Pollard J. Rejman W. De Haes B. Verrier E. Van Gulck T. Naessens S. De Smedt P. Bogaert J. Grooten G. Vanham et al., Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines Mol. Ther. 2013 21 251 259
40. K. Kariko H. P. Ni J. Capodici M. Lamphier D. Weissman mRNA is an endogenous ligand for Toll-like receptor 3 J. Biol. Chem. 2004 279 12542 12550
41. M. Fotin-Mleczek K. M. Duchardt C. Lorenz R. Pfeiffer S. Ojkic-Zrna J. Probst K. J. Kallen Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity J. Immunother. 2011 34 1 15
42. S. Akira K. Takeda T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat. Immunol. 2001 2 675 680
43. R. R. Kulkarni M. A. U. Rasheed S. K. Bhaumik P. Ranjan W. P. Cao C. Davis K. Marisetti S. Thomas S. Gangappa S. Sambhara et al., Activation of the RIG-I Pathway during Influenza Vaccination Enhances the Germinal Center Reaction, Promotes T Follicular Helper Cell Induction, and Provides a Dose-Sparing Effect and Protective Immunity J. Virol. 2014 88 13990 14001
44. K. A. O. Martins J. T. Steffens S. A. van Tongeren J. B. Wells A. A. Bergeron S. P. Dickson J. M. Dye A. M. Salazar S. Bavari Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation PLoS One 2014 9 e89735 10.1371/journal.pone.0089735
45. S. P. Kasturi I. Skountzou R. A. Albrecht D. Koutsonanos T. Hua H. I. Nakaya R. Ravindran S. Stewart M. Alam M. Kwissa et al., Programming the magnitude and persistence of antibody responses with innate immunity Nature 2011 470 543
46. S. R. Nallagatla J. Hwang R. Toroney X. F. Zheng C. E. Cameron P. C. Bevilacqua 5′-triphosphate-dependent activation of PKR by RNAs with short stem-loops Science 2007 318 1455 1458
47. L. A. Heinicke S. R. Nallagatla C. M. Hull P. C. Bevilacqua RNA helical imperfections regulate activation of the protein kinase PKR: effects of bulge position, size, and geometry Rna 2011 17 957 966
48. J. Z. Zhu Y. G. Zhang A. Ghosh R. A. Cuevas A. Forero J. Dhar M. S. Ibsen J. L. Schmid-Burgk T. Schmidt M. K. Ganapathiraju et al., Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of the RIG-I RNA Sensor Immunity 2014 40 936 948
49. R. H. Silverman Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response J. Virol. 2007 81 12720 12729
50. V. Hornung R. Hartmann A. Ablasser K. P. Hopfner OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids Nat. Rev. Immunol. 2014 14 521 528
51. A. N. Harman C. R. Bye N. Nasr K. J. Sandgren M. Kim S. K. Mercier R. A. Botting S. R. Lewin A. L. Cunningham P. U. Cameronx Identification of Lineage Relationships and Novel Markers of Blood and Skin Human Dendritic Cells J. Immunol. 2013 190 66 79
52. M. Yoneyama M. Kikuchi T. Natsukawa N. Shinobu T. Imaizumi M. Miyagishi K. Taira S. Akira T. Fujita The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nat. Immunol. 2004 5 730 737
53. B. Wu A. Peisley C. Richards H. Yao X. H. Zeng C. Lin F. X. Chu T. Walz S. Hur Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5 Cell 2013 152 276 289
54. A. Schmidt T. Schwerd W. Hamm J. C. Hellmuth S. Cui M. Wenzel F. S. Hoffmann M. C. Michallet R. Besch K. P. Hopfner et al., 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I Proc. Natl. Acad. Sci. U. S. A. 2009 106 12067 12072
55. M. Schlee G. Hartmann The Chase for the RIG-I Ligand-Recent Advances Mol. Ther. 2010 18 1254 1262
56. K. Malathi B. H. Dong M. Gale R. H. Silverman Small self RNA generated by RNASE L amplifies antiviral innate immunity J. Interferon Cytokine Res. 2007 27 700
57. A. M. Bruns G. P. Leser R. A. Lamb C. M. Horvath The Innate Immune Sensor LGP2 Activates Antiviral Signaling by Regulating MDA5-RNA Interaction and Filament Assembly Mol. Cell 2014 55 771 781
58. M. Muzio D. Bosisio N. Polentarutti G. D'amico A. Stoppacciaro R. Mancinelli C. van't Veer G. Penton-Rol L. P. Ruco P. Allavena et al., Differential expression and regulation of toll-like receptors [TLR] in human leukocytes: Selective expression of TLR3 in dendritic cells J. Immunol. 2000 164 5998 6004
59. S. S. Diebold T. Kaisho H. Hemmi S. Akira C. R. E. Sousa Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA Science 2004 303 1529 1531
60. A. Forsbach J. G. Nemorin C. Montino C. Muller U. Samulowitz A. P. Vicari M. Jurk G. K. Mutwiri A. M. Krieg G. B. Lipford et al., Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses J. Immunol. 2008 180 3729 3738
61. A. Larange D. Antonios M. Pallardy S. Kerdine-Romer TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation J. Leukocyte Biol. 2009 85 673 683
62. L. Rettig S. P. Haen A. G. Bittermann L. von Boehmer A. Curioni S. D. Kramer A. Knuth S. Pascolo Particle size and activation threshold: a new dimension of danger signaling Blood 2010 115 4533 4541
63. G. Q. Zheng J. A. Dahl Y. M. Niu Y. Fu A. Klungland Y. G. Yang C. He Sprouts of RNA epigenetics The discovery of mammalian RNA demethylases RNA Biol. 2013 10 915 918
64. E. Kierzek M. Malgowska J. Lisowiec D. H. Turner Z. Gdaniec R. Kierzek The contribution of pseudouridine to stabilities and structure of RNAs Nucleic Acids Res. 2014 42 3492 3501
65. 2+ and a Conformational Transition at the Anticodon Stem-Loop of Yeast Phenylalanine Transfer-Rna Biochemistry 1993 32 10249 10253
66. Y. Motorin M. Helm tRNA Stabilization by Modified Nucleotides Biochemistry 2010 49 4934 4944
67. D. Sydow F. Leonarski L. D'Ascenzo P. Auffinger Stabilization effects induced by modified nucleotides in tRNA T-loop motifs J. Biomol. Struct. Dyn. 2015 33 66
68. X. Z. X. Li S. Ma J. Song J. Bai F. Sun C. Yi Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome Nat. Chem. Biol. 2015 11 592 597
69. T. M. Carlile M. F. Rojas-Duran B. Zinshteyn H. Shin K. M. Bartoli W. V. Gilbert Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells Nature 2014 515 143 146 10.1038/nature13802
70. S. Schwartz D. A. Bernstein M. R. Mumbach M. Jovanovic R. H. Herbst B. X. Leon-Ricardo J. M. Engreitz M. Guttman R. Satija E. S. Lander et al., Transcriptome-wide Mapping Reveals Widespread Dynamic-Regulated Pseudouridylation of ncRNA and mRNA Cell 2014 159 148 162
71. X. Wang Z. K. Lu A. Gomez G. C. Hon Y. N. Yue D. L. Han Y. Fu M. Parisien Q. Dai G. F. Jia et al., N-6-methyladenosine-dependent regulation of messenger RNA stability Nature 2014 505 117 120
72. Y. Motorin M. Helm RNA nucleotide methylation Wires RNA 2011 2 611 631
73. S. R. Nallagatla C. N. Jones S. K. B. Ghosh S. D. Sharma C. E. Cameron L. L. Spremulli P. C. Bevilacqua Native Tertiary Structure and Nucleoside Modifications Suppress tRNA's Intrinsic Ability to Activate the Innate Immune Sensor PKR PLoS One 2013 8 e57905 10.1371/journal.pone.0057905
74. S. R. Nallagatla P. C. Bevilacqua Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner RNA 2008 14 1201 1213
75. L. E. Mays S. Ammon-Treiber B. Mothes M. Alkhaled J. Rottenberger E. S. Muller-Hermelink M. Grimm M. Mezger S. Beer-Hammer E. von Stebut et al., Modified Foxp3 mRNA protects against asthma through an IL-10 dependent mechanism J. Clin. Invest. 2013 123 1216 1228
76. I. S. Fernandez C. L. Ng A. C. Kelley G. W. Wu Y. T. Yu V. Ramakrishnan Unusual base pairing during the decoding of a stop codon by the ribosome Nature 2013 500 107
77. J. Karijolich Y. T. Yu Converting nonsense codons into sense codons by targeted pseudouridylation Nature 2011 474 395 398
78. M. Parisien C. Yi T. Pan Rationalization and prediction of selective decoding of pseudouridine-modified nonsense and sense codons RNA 2012 18 355 367
79. C. Gustafsson S. Govindarajan J. Minshull Codon bias and heterologous protein expression Trends Biotechnol. 2004 22 346 353
80. J. B. Duan J. X. Shi X. J. Ge L. Dolken W. Moy D. L. He S. Shi A. R. Sanders J. Ross P. V. Gejman Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines Sci. Rep. 2013 3 1318
81. R. Saunders C. M. Deane Synonymous codon usage influences the local protein structure observed Nucleic Acids Res. 2010 38 6719 6728
82. J. B. Plotkin G. Kudla Synonymous but not the same: the causes and consequences of codon bias Nat. Rev. Genet. 2011 12 32 42
83. K. C. Ngumbela K. P. Ryan R. Sivamurthy M. A. Brockman R. T. Gandhi N. Bhardwaj D. G. Kavanagh Quantitative Effect of Suboptimal Codon Usage on Translational Efficiency of mRNA Encoding HIV-1 gag in Intact T Cells PLoS One 2008 3 e2356 10.1371/journal.pone.0002356
84. P. Gaspar G. Moura M. A. S. Santos J. L. Oliveira mRNA secondary structure optimization using a correlated stem-loop prediction Nucleic Acids Res. 2013 41 e73 10.1093/nar/gks1473
85. K. E. Griswold N. A. Mahmood B. L. Iverson G. Georgiou Effects of codon usage versus putative 5′-mRNA structure on the expression of Fusarium solani cutinase in the Escherichia coli cytoplasm Protein Expression Purif. 2003 27 134 142
86. W. C. Zhang W. H. Xiao H. M. Wei J. Zhang Z. G. Tian mRNA secondary structure at start AUG codon is a key limiting factor for human protein expression in Escherichia coli Biochem. Biophys. Res. Commun. 2006 349 69 78
87. S. Fath A. P. Bauer M. Liss A. Spriestersbach B. Maertens P. Hahn C. Ludwig F. Schafer M. Graf R. Wagner Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression PLoS One 2011 6 e17596 10.1371/journal.pone.0017596
88. C. Gustafsson J. Minshull S. Govindarajan J. Ness A. Villalobos M. Welch Engineering genes for predictable protein expression Protein Expression Purif. 2012 83 37 46
89. J. V. Chamary J. L. Parmley L. D. Hurst Hearing silence: non-neutral evolution at synonymous sites in mammals Nat. Rev. Genet. 2006 7 98 108
90. S. G. E. Andersson C. G. Kurland Codon Preferences in Free-Living Microorganisms Microbiol. Rev. 1990 54 198 210
91. S. Holtkamp S. Kreiter A. Selmi P. Simon M. Koslowski C. Huber O. Tureci U. Sahin Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells Blood 2006 108 4009 4017
92. G. Tavernier O. Andries J. Demeester N. N. Sanders S. C. De Smedt J. Rejman mRNA as gene therapeutic: How to control protein expression J. Controlled Release 2011 150 238 247
93. J. Devoldere H. Dewitte S. C. De Smedt K. Remaut Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger Drug Discovery Today 2015 10.1016/j.drudis.2015.07.009
94. G. Sahay D. Y. Alakhova A. V. Kabanov Endocytosis of nanomedicines J. Controlled Release 2010 145 182 195
95. P. Midoux C. Pichon Lipid-based mRNA vaccine delivery systems Expert Rev. Vaccines 2015 14 221 234
96. M. P. Gantier S. Tong M. A. Behlke D. Xu S. Phipps P. S. Foster B. R. G. Williams TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages J. Immunol. 2008 180 2117 2124
97. J. Probst B. Weide B. Scheel B. J. Pichler I. Hoerr H. G. Rammensee S. Pascolo Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent (vol 14, pg 1175, 2007) Gene Ther. 2009 16 706
98. K. K. L. Phua K. W. Leong S. K. Nair Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format J. Controlled Release 2013 166 227 233
99. I. E. Palama B. Cortese S. D'Amone G. Gigli mRNA delivery using non-viral PCL nanoparticles Biomater. Sci. 2015 3 144 151
100. F. T. Zohra E. H. Chowdhury T. Akaike High performance mRNA transfection through carbonate apatite-cationic liposome conjugates Biomaterials 2009 30 4006 4013
101. K. K. L. Phua H. F. Staats K. W. Leong S. K. Nair Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity Sci. Rep. 2014 4 5128 10.1038/srep05128
102. D. M. Anderson L. L. Hall A. R. Ayyalapu V. R. Irion M. H. Nantz J. G. Hecker Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: Methods and evidence for nonviral mRNA gene delivery to the central nervous system Hum. Gene Ther. 2003 14 191 202
103. X. F. Su J. Fricke D. G. Kavanagh D. J. Irvine In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles Mol. Pharmaceutics 2011 8 774 787
104. B. Scheel S. Aulwurm J. Probst L. Stitz I. Hoerr H. G. Rammensee M. Weller S. Pascolo Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA Eur. J. Immunol. 2006 36 2807 2816
105. B. Scheel R. Teufel J. Probst J. P. Carralot J. Geginat M. Radsak D. Jarrossay H. Wagner G. Jung H. G. Rammensee et al., Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA Eur. J. Immunol. 2005 35 1557 1566
106. D. N. Nguyen K. P. Mahon G. Chikh P. Kim H. Chung A. P. Vicari K. T. Love M. Goldberg S. Chen A. M. Krieg et al., Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery Proc. Natl. Acad. Sci. U. S. A. 2012 109 E797 E803
107. C. Cheng A. J. Convertine P. S. Stayton J. D. Bryers Multifunctional triblock copolymers for intracellular messenger RNA delivery Biomaterials 2012 33 6868 6876
108. S. Uchida K. Itaka H. Uchida K. Hayakawa T. Ogata T. Ishii S. Fukushima K. Osada K. Kataoka In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle PLoS One 2013 8 e56220 10.1371/journal.pone.0056220
109. F. Perche T. Benvegnu M. Berchel L. Lebegue C. Pichon P. A. Jaffres P. Midoux Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA J. Nanomed. Nanotechnol. 2011 7 445 453
110. B. Weide S. Pascolo B. Scheel E. Derhovanessian A. Pflugfelder T. K. Eigentler G. Pawelec I. Hoerr H. G. Rammensee C. Garbe Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients J. Immunother. 2009 32 498 507
111. P. Crowley Baumhover and Rice. Efficient expression of stabilized mRNA PEG-peptide polyplexes in liver Gene Ther. 2015 10.1038/mt.2010.289
112. S. M. Rittig M. Haentschel K. J. Weimer A. Heine M. R. Muller W. Brugger M. S. Horger O. Maksimovic A. Stenzl I. Hoerr et al., Intradermal Vaccinations With RNA Coding for TAA Generate CD8[+] and CD4[+] Immune Responses and Induce Clinical Benefit in Vaccinated Patients Mol. Ther. 2011 19 990 999
113. I. F. N. Hung A. J. Zhang K. K. W. To J. F. W. Chan C. Li H. S. Zhu P. Li C. Li T. C. Chan V. C. C. Cheng et al., Immunogenicity of Intradermal Trivalent Influenza Vaccine With Topical Imiquimod: A Double Blind Randomized Controlled Trial Clin. Infect. Dis. 2014 59 1246 1255
114. S. Kreiter A. Selmi M. Diken M. Koslowski C. M. Britten C. Huber O. Tureci U. Sahin Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity Cancer Res. 2010 70 9031 9040
115. M. Longmire P. L. Choyke H. Kobayashi Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats Nanomedicine 2008 3 703 717
116. A. Fasbender J. Zabner B. G. Zeiher M. J. Welsh A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia Gene Ther. 1997 4 1173 1180
117. H. Matsui L. G. Johnson S. H. Randell R. C. Boucher Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells J. Biol. Chem. 1997 272 1117 1126
118. W. J. Li F. C. Szoka Lipid-based nanoparticles for nucleic acid delivery Pharm. Res. 2007 24 438 449
119. P. J. Santangelo A. W. Lifland P. Curt Y. Sasaki G. J. Bassell M. E. Lindquist J. E. Crowe Single molecule-sensitive probes for imaging RNA in live cells Nat. Methods 2009 6 347
120. J. Jung A. W. Lifland C. Zurla E. J. Alonas P. J. Santangelo Quantifying RNA-protein interactions in situ using modified-MTRIPs and proximity ligation Nucleic Acids Res. 2013 41 e12 10.1093/nar/gks837
121. C. A. McHugh P. Russell M. Guttman Methods for comprehensive experimental identification of RNA-protein interactions Genome Biol. 2014 15 10.1186/gb4152
122. R. A. Flynn L. Martin R. C. Spitale B. T. Do S. M. Sagan B. Zarnegar K. Qu P. A. Khavari S. R. Quake P. Sarnow et al., Dissecting noncoding and pathogen RNA-protein interactomes RNA 2015 21 135 143